Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 8

1.

Resveratrol, a neuroprotective supplement for Alzheimer's disease.

Li F, Gong Q, Dong H, Shi J.

Curr Pharm Des. 2012;18(1):27-33. Review.

PMID:
22211686
2.

Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease.

Chang J, Rimando A, Pallas M, Camins A, Porquet D, Reeves J, Shukitt-Hale B, Smith MA, Joseph JA, Casadesus G.

Neurobiol Aging. 2012 Sep;33(9):2062-71. doi: 10.1016/j.neurobiolaging.2011.08.015. Epub 2011 Oct 7.

PMID:
21982274
3.

Dietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8.

Porquet D, Casadesús G, Bayod S, Vicente A, Canudas AM, Vilaplana J, Pelegrí C, Sanfeliu C, Camins A, Pallàs M, del Valle J.

Age (Dordr). 2013 Oct;35(5):1851-65. doi: 10.1007/s11357-012-9489-4. Epub 2012 Nov 7.

4.

Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease.

Karuppagounder SS, Pinto JT, Xu H, Chen HL, Beal MF, Gibson GE.

Neurochem Int. 2009 Feb;54(2):111-8. doi: 10.1016/j.neuint.2008.10.008. Epub 2008 Nov 8.

5.

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

Marambaud P, Zhao H, Davies P.

J Biol Chem. 2005 Nov 11;280(45):37377-82. Epub 2005 Sep 14.

6.

Resveratrol--a boon for treating Alzheimer's disease?

Anekonda TS.

Brain Res Rev. 2006 Sep;52(2):316-26. Review.

PMID:
16766037
7.

Therapeutic potential of resveratrol in Alzheimer's disease.

Vingtdeux V, Dreses-Werringloer U, Zhao H, Davies P, Marambaud P.

BMC Neurosci. 2008 Dec 3;9 Suppl 2:S6. doi: 10.1186/1471-2202-9-S2-S6. Review.

8.

Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer's disease.

Lu C, Guo Y, Yan J, Luo Z, Luo HB, Yan M, Huang L, Li X.

J Med Chem. 2013 Jul 25;56(14):5843-59. doi: 10.1021/jm400567s. Epub 2013 Jul 8.

PMID:
23799643

Supplemental Content

Support Center